Premium
TPG Growth, the mid-market and growth equity platform of private equity firm TPG, has bet on a bulks drug company in its second...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
